Invitrogen™ Chlamydia trachomatis LPS Monoclonal Antibody (CL21-335.2.3), Invitrogen™

Description

MA1-10677 detects Chlamydia trachomatis LPS from C. trachomatis serovars A, B, Ba, C, D, E, F, G, H, I, J, K, L1, L2, and L3 samples. MA1-10677 may be used in immunoassays to detect C. trachomatis. The MA1-10677 immunogen is C. trachomatis elementary bodies.

Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%. Chlamydia is one of the leading causes of blindness in underdeveloped countries.